Table 1.
Results of genome-scale,a cell-based RNAi high-throughput screens in mammalian or Drosophila cells
Cell type | Screen type | Reagent | Primary hits | Secondary hitsb | Field of study | References |
---|---|---|---|---|---|---|
Human cells | ||||||
HeLa | Plate reader & imaging | esiRNA | 275 | 37 | Cell division | 120, 121 |
U2OS | Imaging | siRNA | 1,152 | 18 | Cell cycle | 114 |
NCI-H1155 | Plate reader | siRNA | 87 | 6 | Cancer biology | 103 |
NIH3T3 | Pooled | shRNA | 15 | 3 | Stress resistance | 43 |
293T | Plate reader | siRNA | — | 295 | Host-pathogen interactions | 79 |
293T, HeLa, MCF-7 | Pooled | shRNA | 30 | 8 | Cell death | 42 |
DLD1 | Plate reader | siRNA | 740 | 268 | Signal transduction | 50 |
HEK293 | Pooled | shRNA | 13,140 | 21 | Cell adhesion | 40 |
HeLa | Imaging | siRNA | 305 | 124 | Host-pathogen interactions | 180 |
HeLa | Plate reader | siRNA | 530 | 23 | Signal transduction | 156 |
HeLa-derived TZM-b1 | Plate reader | siRNA | 386 | 273 | Host-pathogen interactions | 78 |
HeLa P4/R5 | Plate reader | siRNA | 931 | 232 | Host-pathogen interactions | 80 |
Jurkat | Pooled | shRNA | 11 | 5 | Cancer biology | 46 |
MCF-10Ac | Pooled | shRNA | 201 | 166 | Cancer biology | 45 |
MNT-1 | Plate reader | siRNA | 98 | 35 | Pigmentation | 142 |
RDG3 | Imaging | siRNA | — | 171 | Stress resistance | 133 |
BJtsLT | Pooled | shRNA | 100 | 37 | Cancer biology | 126 |
DLD-1 | Pooled | shRNA | 368 | 83 | Cancer biology | 48 |
Huh7/Rep-Feo | Plate reader | siRNA | 236 | 96 | Host-pathogen interactions | 181 |
Jurkat | Pooled | shRNA | 252 | 7 | Host-pathogen interactions | 47 |
Huh 7.5.1 | Imaging | siRNA | 521 | 262 | Host-pathogen interactions | 182 |
Mouse cells | ||||||
NIH 3T3 | Pooled | shRNA | — | 28 | Cancer biology | 104 |
L929 | Plate reader | siRNA | 666 | 432 | Cell death | 122 |
B16-F0 | Pooled | shRNA | 78 | 22 | Cancer biology | 41 |
Oct4-Gip ESCs | FACSd & imaging | esiRNA | 296 | 21 | Stem cell biology | 109 |
Oct4-Gip ESCs | FACS | siRNA | 148 | 104 | Stem cell biology | 107 |
Drosophila cells | ||||||
Kc167, S2R+ | Imaging | dsRNA | 438 | — | Viability | 97 |
S2 | Imaging | dsRNA | — | 121 | Host-pathogen interactions | 164 |
Clone 8 | Plate reader | dsRNA | 238 | 213 | Signal transduction | 152 |
Clone 8 | Plate reader | dsRNA | 509 | 96 | Signal transduction | 147 |
Kc167 | Plate reader | dsRNA | — | 90 | Signal transduction | 149 |
S2 | Plate reader | dsRNA | 474 | 121 | Signal transduction | 190 |
S2 | Imaging | dsRNA | — | 86 | Host-pathogen interactions | 167 |
S2 | Imaging | dsRNA | 305 | ~190 | Host-pathogen interactions | 169 |
S2 | Imaging | dsRNA | 210 | 112 | Host-pathogen interactions | 176 |
S2 | Plate reader | dsRNA | — | 14 | Host-pathogen interactions | 163, 191 |
S2 | Plate reader | dsRNA | 1,133 | 284 | Protein secretion | 139 |
S2 | FACS | dsRNA | 488 | — | Cell cycle and/or cell size | 115 |
S2 | Imaging | dsRNA | — | — | Signal transduction | 130 |
S2 | FACS | dsRNA | 66 | 23 | RNA biology | 157 |
S2 | Plate reader | dsRNA | 75 | 4 | Ion transport | 129 |
S2R+ | Plate reader | dsRNA | 138 | 7 | RNA biology | 158 |
S2R+ | Plate reader | dsRNA | 1,168 | 331 | Signal transduction | 144 |
S2R+ | Imaging | dsRNA | 699 | — | Signal transduction | 131 |
S2R+ | Imaging | dsRNA | 1,500 | 27 | Signal transduction | 132 |
S2 | Imaging | dsRNA | 90 | 24 | RNA biology | 162 |
Kc167 | Plate reader | dsRNA | 81 | 47 | Cell death | 123 |
S2 | Plate reader | dsRNA | 47 | 1 | RNA biology | 159 |
S2* | Plate reader | dsRNA | 18 | 5 | Chromatin regulation | 140 |
S2R+ | Imaging | dsRNA | 346 | — | Signal transduction | 145a |
S2 | Imaging | dsRNA | 162 | 54 | Host-pathogen interactions | 173 |
DL1 | Plate reader | dsRNA | 176 | 110 | Host-pathogen interactions | 178 |
Kc167 | Imaging | dsRNA | 526 | — | Lipids | 82 |
Kc167 | Plate reader | dsRNA | 265 | 120 | Transcription and/or translation | 141 |
Primary neurons | Imaging | dsRNA | 336 | 104 | Neural outgrowth | 136 |
S2 | Plate reader | dsRNA | 821 | 152 | Mitochondria | 138 |
S2 | Plate reader | dsRNA | — | — | Phagocytosis | 128 |
S2 | Imaging | dsRNA | — | — | Centrioles and/or centrosomes | 119 |
S2 | Imaging | dsRNA | 847 | 227 | Lipids | 83 |
S2 | Imaging | dsRNA | 292 | 133 | Cancer biology | 117 |
S2 | Imaging | dsRNA | 23 | — | Transcription and/or translation | 85 |
S2-derived RZ-14 | Plate reader | dsRNA | 177 | — | RNA biology | 160 |
S2R+ | Imaging | dsRNA | 119 | 39 | Centrioles and/or centrosomes | 118 |
S2R+ | Imaging | dsRNA | 133 | 72 | RNA biology | 161 |
S2R+ | Imaging | dsRNA | ~500 | 1 | Mitochondria | 137 |
S2R+ | Plate reader | dsRNA | 303 | 173 | Circadian rhythms | 125 |
Clone 8 | Plate reader | dsRNA | ~100 | 11 | Signal transduction | 155 |
S2 | Plate reader | dsRNA | 218 | 116 | Host-pathogen interactions | 37 |
Kc167 | Plate reader | dsRNA | 996 | 202 | Cell cycle and/or cell size | 116 |
S2R+ | Plate reader | dsRNA | 42 | 33 | Cell death | 124 |
S2R+ | Imaging | dsRNA | — | — | Signal transduction | 154 |
S2R+ | Imaging | dsRNA | 15 | 7 | Cell cycle and/or cell size | 134 |
For this summary, we defined genome-scale with a cutoff of approximately 5000 genes (mammalian cell screens) or at least 70% of the genome (Drosophila cell screens).
Here, we use secondary hits to refer to the largest set of primary hits that passed an additional test verifying the result at the reagent level (retest after re-synthesis or with another assay or cell type) or in most cases, at the gene level (retest with another reagent or single reagents from a pool, for example). In some cases, only a subset of primary hits were tested in secondary assays. For most reports, only a small number of genes (typically, one to five) were confirmed with a rigorous test, such as rescue of the RNAi effect with a cDNA, or were confirmed at the level of biological significance with another type of assay or an in vivo analysis.
Additional cell types tested with smaller shRNA pools.
FACS, fluorescence-activated cell sorter.